Insider Transactions Reported by 26 Insiders of Ernexa Therapeutics Inc.

Symbol
ERNA on Nasdaq
Location
Cambridge, MA

Insiders trading volume in the past year

Ernexa Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Matthew Angel President and CEO, Director $8,654,371 12 Jan 2023
Charles Cherington 10%+ Owner $4,357,609 +$2,221,826 +104% 09 Jun 2025
Freebird Partners LP 10%+ Owner $1,503,337 14 Dec 2023
GEORGE P. DENNY III 10%+ Owner $1,134,456 02 Dec 2022
JOHN D. HALPERN 10%+ Owner $1,118,891 02 Dec 2022
Nicholas J. Singer Director $1,033,152 02 Dec 2022
Roger Sidhu Chief Medical Officer $200,012 20 Sep 2022
Kevin DAmour Chief Scientific Officer $159,248 28 Jun 2022
Jay Sial Chief Administration Officer $88,536 11 Mar 2022
BINDER BRANT Former director $10,490 08 Aug 2023
RICHARD W. WAGNER Former director $10,490 08 Aug 2023
Sandra Gurrola Sr. VP of Finance $1,107 21 Jun 2025
ERIN S. ENRIGHT Director 14 Jan 2022
Howard J. Federoff CEO & President, Director 11 Mar 2022
DENNIS LANGER Director 08 Dec 2021
Erich Mohr Director 08 Dec 2021
Gregory Fiore Director 01 Aug 2022
Heather B. Redman Director 14 Jan 2022
Luba Greenwood Director 08 Dec 2021
Andrew Jackson Chief Financial Officer 03 Jun 2022
William Wexler Director 07 Feb 2025
Elena Ratner Director 13 Jan 2025
James Arthur Bristol Director 07 Feb 2025
Sanjeev Luther President & CEO, Director 07 Feb 2025
Peter Cicala Director 07 Feb 2025
Dorothy Clarke General Counsel, Director 01 Jan 2024

Recent Insider Transactions by Companies or Individuals for Ernexa Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.